Correlation Between Neurocrine Biosciences and L3HARRIS

Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and L3HARRIS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and L3HARRIS into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neurocrine Biosciences and L3HARRIS TECHNOLOGIES INC, you can compare the effects of market volatilities on Neurocrine Biosciences and L3HARRIS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of L3HARRIS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and L3HARRIS.

Diversification Opportunities for Neurocrine Biosciences and L3HARRIS

-0.09

Correlation Coefficient

Neurocrine Biosciences  L3HARRIS

Good diversification

The 3 months correlation between Neurocrine and L3HARRIS is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and L3HARRIS TECHNOLOGIES INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on L3HARRIS TECHNOLOGIES INC and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with L3HARRIS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of L3HARRIS TECHNOLOGIES INC has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and L3HARRIS go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and L3HARRIS

Given the investment horizon of 90 days Neurocrine Biosciences is expected to under-perform the L3HARRIS. In addition to that, Neurocrine Biosciences is 3.94 times more volatile than L3HARRIS TECHNOLOGIES INC. It trades about -0.1 of its total potential returns per unit of risk. L3HARRIS TECHNOLOGIES INC is currently generating about -0.09 per unit of volatility. If you would invest  9,826  in L3HARRIS TECHNOLOGIES INC on December 30, 2024 and sell it today you would lose (418.00) from holding L3HARRIS TECHNOLOGIES INC or give up 4.25% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.41%
Values	Daily Returns

Neurocrine Biosciences  vs.  L3HARRIS TECHNOLOGIES INC

Neurocrine Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neurocrine Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

L3HARRIS TECHNOLOGIES INC

Risk-Adjusted Performance

Very Weak

Over the last 90 days L3HARRIS TECHNOLOGIES INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, L3HARRIS is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Neurocrine Biosciences and L3HARRIS

The main advantage of trading using opposite Neurocrine Biosciences and L3HARRIS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, L3HARRIS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in L3HARRIS will offset losses from the drop in L3HARRIS's long position.

The idea behind Neurocrine Biosciences and L3HARRIS TECHNOLOGIES INC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.